In humans and rodents, the lysosomal catabolism of core Man 3 GlcNAc 2 N-glycan structures is catalyzed by the concerted action of several exoglycosidases, including a broad specificity lysosomal ␣-mannosidase (LysMan), core-specific ␣1,6-mannosidase, -mannosidase, and cleavage at the reducing terminus by a di-Nacetylchitobiase. We describe here the first cloning, expression, purification, and characterization of a novel human glycosylhydrolase family 38 ␣-mannosidase with catalytic characteristics similar to those established previously for the core-specific ␣1,6-mannosidase (acidic pH optimum, inhibition by swainsonine and 1,4-dideoxy-1,4-imino-D-mannitol, and stimulation by Co 2؉ and Zn
2؉). Substrate specificity studies comparing the novel human ␣-mannosidase with human LysMan revealed that the former enzyme efficiently cleaved only the ␣1-6mannose residue from Man 3 GlcNAc but not Man 3 GlcNAc 2 or other larger high mannose oligosaccharides, indicating a requirement for chitobiase action before ␣1,6-mannosidase activity. In contrast, LysMan cleaved all of the ␣-linked mannose residues from high mannose oligosaccharides except the core ␣1-6mannose residue. ␣1,6-Mannosidase transcripts were ubiquitously expressed in human tissues, and expressed sequence tag searches identified homologous sequences in murine, porcine, and canine databases. No expressed sequence tags were identified for bovine ␣1,6-mannosidase, despite the identification of two sequence homologs in the bovine genome. The lack of conservation in 5-flanking sequences for the bovine ␣1,6-mannosidase genes may lead to defective transcription similar to transcription defects in the bovine chitobiase gene. These results suggest that the chitobiase and ␣1,6-mannosidase function in tandem for mammalian lysosomal N-glycan catabolism.